MedImmune
Healthcare, Pharmaceuticals, and Biotech
Company overview
MedImmune is a US-based biotechnology company that specializes in the development of novel immunotherapies for the prevention and treatment of infectious diseases, cancers, and other serious medical conditions. It was founded in 1988 and later acquired by AstraZeneca in 2007. MedImmune's products and pipeline focus on innovative biologics, including monoclonal antibodies, fusion proteins, and vaccines. Key products include Synagis for the prevention of respiratory syncytial virus (RSV) in infants, FluMist Quadrivalent, a nasal spray flu vaccine, and Imfinzi, an immunotherapy for the treatment of non-small cell lung cancer. The company is headquartered in Gaithersburg, Maryland, and has operations in California, Colorado, and the United Kingdom.
Available Jobs at MedImmune
Top C-suite Members of Company
Connect with key decision-makers at MedImmune. View the C-suite executives and leadership team.
Leadership information is not available.
Employees Contact
Connect with company employees using the separately sourced, masked contact dataset.
Email formats
Discover the professional email patterns used at MedImmune.
| Email format | Example | Percentage |
|---|---|---|
| Email formats for MedImmune are not available. | ||
Email verification tool
Find and verify professional email addresses for MedImmune.
No technology stack information available.